Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a research note released on Monday. The brokerage issued a hold rating on the medical device company’s stock.

Avinger Price Performance

AVGR opened at $0.47 on Monday. Avinger has a fifty-two week low of $0.36 and a fifty-two week high of $4.37. The firm has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. The company’s 50 day moving average price is $0.55 and its two-hundred day moving average price is $0.79.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.